Our Services
Medical Information
Helpful Resources
Published on: 7/21/2026
Zepbound and Heart Rate: What to Know
A mild resting heart rate increase of 5–10 beats per minute is common when starting Zepbound (tirzepatide) and typically resolves within 4–6 weeks. More noticeable palpitations may occur due to dehydration, gastrointestinal side effects, or blood sugar fluctuations.
Key monitoring tips include: tracking your pulse regularly, staying hydrated with adequate electrolytes, and watching for red flags such as a resting heart rate above 100 bpm, persistent palpitations, chest pain, or dizziness. These symptoms warrant prompt medical advice and may require a dose adjustment.
Because palpitations can stem from many causes—medication, dehydration, thyroid issues, anxiety, or arrhythmias—identifying the root cause matters. Take a free, instant, online symptom check to better understand your symptoms and confidently navigate your next steps.
Reviewed for medical accuracy: 07/21/2026
Many patients taking Zepbound (tirzepatide) report feeling their heart race at times. Below, we'll explore why this may happen, when it's expected, and what steps you can take to stay safe. This information is based on clinical trial data, prescribing information, and peer-reviewed studies—always consult your own physician for personalized guidance.
Zepbound (generic name: tirzepatide) is a dual GIP/GLP-1 receptor agonist approved for chronic weight management and type 2 diabetes. It works by:
While highly effective for weight loss and blood sugar control, Zepbound can cause side effects—some of which may influence your heart rate.
A mild uptick in heart rate (tachycardia) is reported by a small percentage of patients on Zepbound. Possible explanations include:
Gastrointestinal Side Effects
Autonomic Nervous System Changes
Weight Loss
Blood Sugar Fluctuations
Stress and Anxiety
It's normal to have some variation in heart rate when starting Zepbound. Common patterns include:
Contact your healthcare provider if you experience:
These could signal dehydration, significant hypoglycemia, or a rare cardiac reaction requiring prompt evaluation.
Being proactive can help you manage mild tachycardia and spot red flags early:
Seek immediate medical attention (call 911 or your local emergency number) if you experience:
If your heart feels faster but you have no other warning signs, try these steps:
Stay Hydrated
• Aim for at least 8–10 cups of water daily.
• Add electrolytes if you have vomiting or diarrhea.
Balance Electrolytes
• Include a pinch of salt or low-sodium sports drink.
• Eat potassium-rich foods (bananas, spinach).
Practice Slow Position Changes
• Rise slowly from lying to standing to avoid "orthostatic" palpitations.
Limit Stimulants
• Reduce caffeine, nicotine, and other stimulants.
• Avoid intense exercise within 2 hours of your injection.
Stress Management
• Deep breathing, meditation, or gentle yoga can calm the autonomic system.
• Consider cognitive strategies or talk therapy if anxiety persists.
Never change your dose without medical guidance. Your doctor may suggest:
These adjustments can reduce peak-effect symptoms, including heart racing.
Sometimes a racing heart is one piece of a broader symptom pattern. If you're experiencing multiple concerning symptoms alongside your elevated heart rate, you may benefit from getting a comprehensive evaluation of what you're experiencing with a Medically approved LLM Symptom Checker Chat Bot to help identify patterns and guide your conversation with your healthcare provider.
While occasional heart racing on Zepbound can be benign, never ignore serious or life-threatening signs. Always speak to a healthcare professional if you experience concerning symptoms. Your doctor knows your medical history best and can tailor advice or testing to keep you safe.
(References)
* Zhao S, Song W, Yu X, He B. Cardiovascular safety of tirzepatide: A meta-analysis of phase 3 randomized controlled trials. J Diabetes. 2023 Dec;15(12):1047-1055. PMID: 37626998.
* Tews MC, Tews PA. GLP-1 Receptor Agonists and Their Effects on Heart Rate: A Narrative Review. Curr Cardiovasc Risk Rep. 2022 Aug;16(8):179-185. PMID: 35920364.
* Sattar N, McLaren J, Neagoe R, Kolopp M. Safety and Tolerability of Tirzepatide in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Diabetes Ther. 2022 Aug;13(8):1377-1393. PMID: 35799307.
* Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. PMID: 35816997.
* Wilding JP, Wilding JP, Wilding JP. Tirzepatide for the Treatment of Obesity: A Review of Efficacy and Safety. Drugs. 2023 Apr;83(5):401-412. PMID: 36730704.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.